Unknown

Dataset Information

0

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.


ABSTRACT: In human breast cancer, loss of carcinoma cell-specific response to TGF-beta signaling has been linked to poor patient prognosis. However, the mechanisms through which TGF-beta regulates these processes remain largely unknown. In an effort to address this issue, we have now identified gene expression signatures associated with the TGF-beta signaling pathway in human mammary carcinoma cells. The results strongly suggest that TGF-beta signaling mediates intrinsic, stromal-epithelial, and host-tumor interactions during breast cancer progression, at least in part, by regulating basal and oncostatin M-induced CXCL1, CXCL5, and CCL20 chemokine expression. To determine the clinical relevance of our results, we queried our TGF-beta-associated gene expression signatures in 4 human breast cancer data sets containing a total of 1,319 gene expression profiles and associated clinical outcome data. The signature representing complete abrogation of TGF-beta signaling correlated with reduced relapse-free survival in all patients; however, the strongest association was observed in patients with estrogen receptor-positive (ER-positive) tumors, specifically within the luminal A subtype. Together, the results suggest that assessment of TGF-beta signaling pathway status may further stratify the prognosis of ER-positive patients and provide novel therapeutic approaches in the management of breast cancer.

SUBMITTER: Bierie B 

PROVIDER: S-EPMC2689133 | biostudies-literature | 2009 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

Bierie Brian B   Chung Christine H CH   Parker Joel S JS   Stover Daniel G DG   Cheng Nikki N   Chytil Anna A   Aakre Mary M   Shyr Yu Y   Moses Harold L HL  

The Journal of clinical investigation 20090518 6


In human breast cancer, loss of carcinoma cell-specific response to TGF-beta signaling has been linked to poor patient prognosis. However, the mechanisms through which TGF-beta regulates these processes remain largely unknown. In an effort to address this issue, we have now identified gene expression signatures associated with the TGF-beta signaling pathway in human mammary carcinoma cells. The results strongly suggest that TGF-beta signaling mediates intrinsic, stromal-epithelial, and host-tumo  ...[more]

Similar Datasets

| S-EPMC4143044 | biostudies-literature
| S-EPMC6429570 | biostudies-literature
| S-EPMC2245859 | biostudies-literature
| S-EPMC3582135 | biostudies-literature
| S-EPMC6563130 | biostudies-literature
| S-EPMC3158717 | biostudies-literature
| S-EPMC2951469 | biostudies-literature
2012-12-06 | E-GEOD-42773 | biostudies-arrayexpress
| S-EPMC3129933 | biostudies-literature
| S-EPMC2812570 | biostudies-literature